A critical role of CXCR 6 in murine myocardial ischemia-reperfusion injury through activating IL-17 a producing iNKT cells

Shijun Wang,Gang Zhao,Feng Zhang,Jian Wu,Lei Xu,Zhen Wang,Peipei Yin,Xingxu Wang,Jieyun You,Ji’e Yang,Junbo Ge,Yunzeng Zou
2016-01-01
Abstract:The pathologic role of invariant natural killer T (iNKT) cells in reperfusion injury after myocardial infarction remains elusive although they induce detrimental inflammatory response in hepatic and renal ischemia/reperfusion (I/R) injury. Here we suppress the activation of iNKT cells by knocking out the chemokine receptor, CXCR6, and investigate the precise role of iNKT cells in cardiac I/R injury. Our data indicate that cardiac infiltrated iNKT cells promote IL-17a secretion and IL-17a-dependent cell apoptosis. IL-17a mRNA and serum level are significantly lower in hearts from CXCR6-/mice than in those from wild-type (WT) mice, and IL-17a producing iNKT cells are also less activated in CXCR6-/mice. Further results confirm that CXCR6 deficiency-mediated cardiac protection against I/R injury is abolished by recombined IL-17a treatment. Left ventricular (LV) infarct size was significantly increased and LV ejection fraction (LVEF) reduced by rIL-17a in CXCR6-/mice, as were decreased expression of Beclin-1 and increased expression of Bax. We therefore conclude that CXCR6 activation is required for myocardial infiltration of IL-17a producing iNKT cells after I/R injury. CXCR6 inhibition before reperfusion period may reduce infarct size and preserve cardiac function partly through attenuating the activity of IL-17a producing iNKT cells.
What problem does this paper attempt to address?